Anti-estrogenresistant breast cancer cells are sensitive to cisplatin plus TRAIL treatment

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1475-1480

Spandidos Publications

Access to resources Recommend Favorite

Protein Kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells

By Frankel Lisa   Lykkesfeldt Anne   Hansen Jens   Stenvang Jan  

Breast Cancer Research and Treatment, Vol. 104, Iss. 2, 2007-08 ,pp. : 165-179

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells

By Smolnikar K.   Löffek S.   Schulz T.   Michna H.   Diel P.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 3, 2000-10 ,pp. : 249-259

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Anthracycline-Resistant Breast Cancer

By Friedman Daniel T.   Sparano Joseph A.  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 151-162

Adis International

Access to resources Recommend Favorite

Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance

By Skildum Andrew  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 785-797

Springer Publishing Company

Access to resources Recommend Favorite